2016
DOI: 10.1002/jbt.21871
|View full text |Cite
|
Sign up to set email alerts
|

Potential urinary biomarkers of nephrotoxicity in cyclophosphamide‐treated rats investigated by NMR‐based metabolic profiling

Abstract: The anticancer-drug cyclophosphamide (CP) is known to have nephrotoxicity. The aim of this study was to identify urinary biomarkers indicating CP-induced nephrotoxicity. We investigated the urine metabolic profiles using nuclear magnetic resonance spectrometry of rats administered with single high-doses of CP (0, 30, and 100 mg/kg body weight) and daily low-doses over a 4-week period (0, 1, 3, and 10 mg/kg body weight). Among 18 identified urinary metabolites, 2-oxoglutarate, citrate, hippurate, formate, valin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
14
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 14 publications
(14 citation statements)
references
References 36 publications
0
14
0
Order By: Relevance
“…Cyclophosphamide [CP], as a cytotoxic alkylating agent used in treatment cancers and as an immunosuppressive agent in organ transplantation and autoimmune diseases [1]. Despite its usefulness, its use due to undesirable effects, including nephrotoxicity, associated with restrictions [2]. Phosphoramide mustard and acrolein, as two of major metabolites of CP induce toxicity [3,4].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Cyclophosphamide [CP], as a cytotoxic alkylating agent used in treatment cancers and as an immunosuppressive agent in organ transplantation and autoimmune diseases [1]. Despite its usefulness, its use due to undesirable effects, including nephrotoxicity, associated with restrictions [2]. Phosphoramide mustard and acrolein, as two of major metabolites of CP induce toxicity [3,4].…”
Section: Introductionmentioning
confidence: 99%
“…Generation of free radicals and oxidative stress is the main mechanism for inducing toxicity [3]. The side effects of CP in cancer patients are glomerular and tubular dysfunction, renal papillary necrosis and pyelonephritis [ 2 ] . In CP-induced nephrotoxicity increase plasma CREA [creatinine] and BUN [Blood Urea Nitrogen] levels, which indicates renal glomerular dysfunction.…”
Section: Introductionmentioning
confidence: 99%
“…This mixture was pipetted into a 5‐mm NMR tube. 1 H‐NMR analyses were performed according to the methods described in our previous report using a 600.13‐MHz Bruker Avance spectrometer (Bruker BioSpin GmbH, Rheinstetten, Germany) (Lim et al, ).…”
Section: Methodsmentioning
confidence: 99%
“…Variables with VIP values >1 were selected as potentially discriminant. 1 H‐NMR data processing and analysis was performed as described previously (Lim et al, ).…”
Section: Methodsmentioning
confidence: 99%
“…Using CP was restricted in spite of its effectiveness because of its organ toxicity as a result ofthe generation of free radicals and oxidative stress [4] .…”
Section: Introductionmentioning
confidence: 99%